Biology of LINE retrotransposition
LINE 逆转录转座的生物学
基本信息
- 批准号:9980955
- 负责人:
- 金额:$ 30.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-02 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAgingAnimal ModelBinding ProteinsBiochemicalBiologicalBiologyCandida albicansCell NucleusCellsComplexDNA DamageDataDevelopmentDiseaseElementsEukaryotaFamilyGene RearrangementGenomeGoalsHumanHuman GenomeInfertilityIntegration Host FactorsKnowledgeMalignant NeoplasmsMembraneMessenger RNAMethodologyMorphologic artifactsMutateMutationNuclearPhenotypePlayProcessProteinsProteomicsRNA BindingRegulationRetrotranspositionRibonucleoproteinsRoleSeaSiteSorting - Cell MovementYeast Model SystemYeastsbasegenetic elementin vivoinhibitor/antagonistinnovationinsightmammalian genomenervous system disordernovelparticle
项目摘要
Long Interspersed Nuclear Elements (LINEs) are a class of retrotransposable elements that continually
mutate genomes, including mammalian genomes. The currently active family of LINEs in humans is called
LINE-1 (L1). To replicate, L1 mRNA and two L1-encoded proteins (called ORF1p and ORF2p) form a
cytoplasmic ribonucleoprotein particle (RNP) intermediate. The L1 RNP enters the nucleus and reverse
transcribes L1 mRNA at new chromosomal sites. This process, called retrotransposition, has been
spectacularly successful in humans and has generated over one-third of the human genome. In addition,
expression of L1 RNPs in humans and/or model organisms is associated with mutations, DNA damage, aging,
and various disorders, such as cancer, infertility, and neurologic disease. In most of these cases we do not
know whether L1 is simply correlated with these disorders, or if L1 plays a causative role in these disorders.
Our inability to convincingly address this question is due to a gap in our rudimentary understanding of LINE
biology, which limits our ability to manipulate endogenous L1 activity in a specific manner. The simplicity of a
typical LINE element belies the complexity of LINE retrotransposition, suggesting that LINE RNPs utilize host
proteins (henceforth referred to as “host factors”) to assist in their replication. Although some host factors that
interact with L1 RNPs have been identified, almost all of these factors are RNA-binding inhibitors that block
retrotransposition, or are artifacts of non-specific RNA binding. We still have little knowledge of the core host
factors that are crucial for a successful round of LINE retrotransposition. This bias towards retrieving L1
inhibitors is likely due to methodology, and alternative strategies are needed for identifying core LINE host
factors. A long term goal in our lab is to address this gap – we want to understand how LINEs replicate,
specifically by identifying and characterizing LINE RNPs/host proteins interactions important for active
retrotransposition. To this end, we have developed a yeast model of LINE retrotransposition, based on the
Candida albicans L1-like element called Zorro3. We have already used this yeast model to discover that the
endosomal sorting complex required for transport (ESCRT) physically interacts with LINE RNPs and is critical
for retrotransposition in both yeast and humans. In this proposal we will further characterize this interaction by
determining where, how, and why the L1/ESCRT interaction takes place (Aim 1). We have also discovered
that LINE retrotransposition occurs in a phenotypically distinct state of Candida albicans called the opaque
state. This finding is the basis for a novel proteomics strategy (Aim 2) to identify biologically relevant host
factors that interact with LINE RNPs. The strategy in Aim 2 addresses a major shortcoming of previous studies
– identifying the biologically significant host factors from the sea of host proteins that bind to L1 RNPs in
biochemical pulldowns.
长散布核元件 (LINE) 是一类逆转录转座元件,持续存在
突变基因组,包括哺乳动物基因组。目前人类中活跃的 LINE 家族称为
LINE-1(L1)。为了复制,L1 mRNA 和两个 L1 编码的蛋白质(称为 ORF1p 和 ORF2p)形成一个
细胞质核糖核蛋白颗粒(RNP)中间体。 L1 RNP进入细胞核并逆转
在新的染色体位点转录 L1 mRNA。这个过程称为逆转录转座,
在人类身上取得了惊人的成功,并产生了超过三分之一的人类基因组。此外,
L1 RNP 在人类和/或模型生物体中的表达与突变、DNA 损伤、衰老、
以及各种疾病,例如癌症、不孕症和神经系统疾病。在大多数情况下,我们不
了解 L1 是否仅与这些疾病相关,或者 L1 是否在这些疾病中起因果作用。
我们无法令人信服地解决这个问题是因为我们对 LINE 的基本理解存在差距
生物学,这限制了我们以特定方式操纵内源性 L1 活性的能力。简单的一个
典型的 LINE 元件掩盖了 LINE 逆转录转座的复杂性,表明 LINE RNP 利用宿主
蛋白质(以下称为“宿主因子”)来协助其复制。尽管一些主机因素
已鉴定出与 L1 RNP 相互作用的因子,几乎所有这些因子都是 RNA 结合抑制剂,可阻断
逆转录转座或非特异性 RNA 结合的产物。我们对核心主机还知之甚少
对于成功进行 LINE 逆转录转座至关重要的因素。这种偏向于检索 L1
抑制剂可能是由于方法论造成的,需要替代策略来识别核心 LINE 宿主
因素。我们实验室的一个长期目标是解决这一差距——我们想了解 LINE 是如何复制的,
特别是通过识别和表征对活性至关重要的 LINE RNP/宿主蛋白相互作用
逆转录转座。为此,我们基于 LINE 逆转录转座的酵母模型开发了
白色念珠菌 L1 样元件称为 Zorro3。我们已经使用这个酵母模型发现
运输所需的内体分选复合物 (ESCRT) 与 LINE RNP 发生物理相互作用,并且至关重要
用于酵母和人类的逆转录转座。在本提案中,我们将进一步描述这种相互作用:
确定 L1/ESCRT 交互发生的地点、方式和原因(目标 1)。我们还发现
LINE 逆转录转座发生在白色念珠菌表型独特的状态(称为不透明状态)中
状态。这一发现是识别生物学相关宿主的新型蛋白质组学策略(目标 2)的基础
与 LINE RNP 相互作用的因素。目标 2 中的策略解决了先前研究的一个主要缺点
– 从与 L1 RNP 结合的宿主蛋白海洋中识别具有生物学意义的宿主因子
生化下拉。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey S Han其他文献
Jeffrey S Han的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey S Han', 18)}}的其他基金
In vivo biology of mammalian L1 retrotransposition
哺乳动物 L1 逆转录转座的体内生物学
- 批准号:
10367362 - 财政年份:2022
- 资助金额:
$ 30.1万 - 项目类别:
In vivo biology of mammalian L1 retrotransposition - supplement
哺乳动物 L1 逆转录转座的体内生物学 - 补充
- 批准号:
10578990 - 财政年份:2022
- 资助金额:
$ 30.1万 - 项目类别:
In vivo biology of mammalian L1 retrotransposition
哺乳动物 L1 逆转录转座的体内生物学
- 批准号:
10549834 - 财政年份:2022
- 资助金额:
$ 30.1万 - 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
- 批准号:
8499365 - 财政年份:2010
- 资助金额:
$ 30.1万 - 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
- 批准号:
8101968 - 财政年份:2010
- 资助金额:
$ 30.1万 - 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
- 批准号:
8294975 - 财政年份:2010
- 资助金额:
$ 30.1万 - 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
- 批准号:
7985631 - 财政年份:2010
- 资助金额:
$ 30.1万 - 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
- 批准号:
8775361 - 财政年份:2010
- 资助金额:
$ 30.1万 - 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
- 批准号:
8686000 - 财政年份:2010
- 资助金额:
$ 30.1万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 30.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 30.1万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 30.1万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 30.1万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 30.1万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 30.1万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 30.1万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 30.1万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 30.1万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 30.1万 - 项目类别:
Continuing Grant














{{item.name}}会员




